NCT02854215Completed
Cost Utility of Radical Surgery in Ovarian Cancer
Source: ClinicalTrials.gov · Last updated 14 Apr 2026
Brief summary (registry, in English)
The purpose of this study is to investigate the medico-economic impact of adherence to INCa (National Cancer Institute) guidelines in ovarian cancer surgery by assessment of outcome in cost per Quality Adjusted Life Years (QALY).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 200 (actual)
- First submitted
- 29 Jul 2016
- Start date
- 18 Jan 2017
- Primary completion date
- 15 Apr 2025
- Lead sponsor
- Institut Claudius Regaud
- Diseases
- Ovarian cancer
- NCT number
- NCT02854215
What you commit to
- Study type: Interventional
- Participants enrolled: 200
- From 18 Jan 2017 to the primary completion date, 15 Apr 2025
- 10 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 3\. Other malignancy diagnosed in the previous 5 years except skin cancer (other than melanoma).
Other illness
- 2\. Patients with extra-abdominal disease, except for pleural effusion with positive cytology.
Other
- 1\. Benign or borderline tumors.
- 4\. Any psychological, familial, geographic or social situation, according to the judgment of investigator, potentially preventing the provision of informed consent or compliance to study procedure.
- 5\. Patient who has forfeited his/her freedom by administrative or legal award or who is under guardianship.
Who the study is looking for
- 1\. Woman with age ≥ 18 years.
- 2\. Newly diagnosed ovarian, tubal or peritoneal malignancies.
- 3\. Epithelial histology.
- 4\. Stage IIIC or IVA with extrapelvic carcinomatosis according to FIGO classification 2014.
- 5\. Patients undergoing primary surgery or neoadjuvant chemotherapy.
- 6\. Performance Status ≤ 2.
- 7\. Patient affiliated to a Social Health Insurance in France.
- 8\. Patient information and informed consent form signed prior to any study specific procedures.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (10)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut Bergonie Coordinator of this site? Confirm its status | Bordeaux | France | Unknown status |
| CHU Clermont-Ferrand Coordinator of this site? Confirm its status | Clermont-Ferrand | France | Unknown status |
| Centre Jean Perrin Coordinator of this site? Confirm its status | Clermont-Ferrand | France | Unknown status |
| Institut Paoli-Calmettes Coordinator of this site? Confirm its status | Marseille | France | Unknown status |
| Institut Régional du Cancer Montpellier Coordinator of this site? Confirm its status | Montpellier | France | Unknown status |
| Institut Curie Coordinator of this site? Confirm its status | Paris | France | Unknown status |
| Centre Hospitalier Lyon Sud 1 Coordinator of this site? Confirm its status | Pierre-Bénite | France | Unknown status |
| Centre Hospitalier Lyon Sud 2 Coordinator of this site? Confirm its status | Pierre-Bénite | France | Unknown status |
| Institut Claudius Regaud Coordinator of this site? Confirm its status | Toulouse | France | Unknown status |
| Hopital Nord Ouest Villefranche sur Saone Coordinator of this site? Confirm its status | Villefranche-sur-Saône | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.